[go: up one dir, main page]

DE60032508D1 - VERFAHREN ZUR VERMEHRUNG VON NATüRLICHEN KILLERZELLEN - Google Patents

VERFAHREN ZUR VERMEHRUNG VON NATüRLICHEN KILLERZELLEN

Info

Publication number
DE60032508D1
DE60032508D1 DE60032508T DE60032508T DE60032508D1 DE 60032508 D1 DE60032508 D1 DE 60032508D1 DE 60032508 T DE60032508 T DE 60032508T DE 60032508 T DE60032508 T DE 60032508T DE 60032508 D1 DE60032508 D1 DE 60032508D1
Authority
DE
Germany
Prior art keywords
natural killer
killer cells
human
reproduction
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60032508T
Other languages
English (en)
Inventor
Riken Ohno
Riken Saijoh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RIKEN
Original Assignee
RIKEN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RIKEN filed Critical RIKEN
Application granted granted Critical
Publication of DE60032508D1 publication Critical patent/DE60032508D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/15—Natural-killer [NK] cells; Natural-killer T [NKT] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0646—Natural killers cells [NK], NKT cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE60032508T 1999-11-26 2000-11-16 VERFAHREN ZUR VERMEHRUNG VON NATüRLICHEN KILLERZELLEN Expired - Lifetime DE60032508D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP33607999A JP3619853B2 (ja) 1999-11-26 1999-11-26 ナチュラルキラー細胞の増殖方法
PCT/JP2000/008079 WO2001038494A1 (en) 1999-11-26 2000-11-16 Method of proliferating natural killer cells

Publications (1)

Publication Number Publication Date
DE60032508D1 true DE60032508D1 (de) 2007-02-01

Family

ID=18295489

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60032508T Expired - Lifetime DE60032508D1 (de) 1999-11-26 2000-11-16 VERFAHREN ZUR VERMEHRUNG VON NATüRLICHEN KILLERZELLEN

Country Status (10)

Country Link
EP (1) EP1233058B1 (de)
JP (1) JP3619853B2 (de)
KR (1) KR20030032905A (de)
CN (1) CN1237170C (de)
AT (1) ATE348876T1 (de)
CA (1) CA2393322A1 (de)
DE (1) DE60032508D1 (de)
HK (1) HK1048498A1 (de)
TW (1) TWI224137B (de)
WO (1) WO2001038494A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1444648A (zh) * 2000-06-06 2003-09-24 麒麟麦酒株式会社 扩增自然杀伤t细胞的方法
JP2002045174A (ja) * 2000-07-31 2002-02-12 Inst Of Physical & Chemical Res ナチュラルキラー細胞増殖法
NZ546174A (en) 2004-09-15 2009-05-31 Morinaga Milk Industry Co Ltd Propagation agent and propagation methods for natural killer cell
RU2327463C2 (ru) 2004-09-29 2008-06-27 Моринага Милк Индастри Ко., Лтд. Лекарственный препарат и пищевой продукт или напиток для улучшения гипергликемического состояния
JP2008109866A (ja) * 2006-10-30 2008-05-15 Jms Co Ltd 培地添加剤、この培地添加剤を含む培地、及びこの培地を用いた細胞の培養方法
MX2007015736A (es) * 2007-12-11 2009-06-11 Val De Bio S De R L De C V Procedimiento para sensibilizar celulas y el uso de las mismas para tratamiento de tumores.
US9511092B2 (en) 2013-01-28 2016-12-06 St. Jude Children's Research Hospital, Inc. Chimeric receptor with NKG2D specificity for use in cell therapy against cancer and infectious disease
AU2015259877B2 (en) 2014-05-15 2021-02-25 National University Of Singapore Modified natural killer cells and uses thereof
CN104611293B (zh) * 2014-12-30 2017-10-13 杭州特马赛生物技术有限公司 一种体外中药组合诱导扩增nk细胞的方法及其应用
CN104789527B (zh) * 2015-05-15 2018-05-29 江苏杰晟生物科技有限公司 一种自体自然杀伤细胞鸡尾酒式培养的制备方法及其试剂盒产品
CN107064085B (zh) * 2017-03-16 2021-05-11 中国人民解放军三〇七医院 自然杀伤细胞活性测定方法
WO2018182511A1 (en) 2017-03-27 2018-10-04 National University Of Singapore Stimulatory cell lines for ex vivo expansion and activation of natural killer cells
BR112019019917A2 (pt) 2017-03-27 2020-04-22 Nat Univ Singapore receptores quiméricos nkg2d truncados e seus usos em imunoterapia de células exterminadoras naturais
AU2019219454A1 (en) 2018-02-09 2020-08-27 National University Of Singapore Activating chimeric receptors and uses thereof in natural killer cell immunotherapy
SG11202008976YA (en) 2018-04-02 2020-10-29 Nat Univ Singapore Neutralization of human cytokines with membrane-bound anti-cytokine non-signaling binders expressed in immune cells
JP7560882B2 (ja) 2018-08-29 2024-10-03 ナショナル ユニヴァーシティー オブ シンガポール 遺伝子修飾免疫細胞の生存及び増加を特異的に刺激するための方法
CN118546959A (zh) 2019-03-05 2024-08-27 恩卡尔塔公司 Cd19定向性嵌合抗原受体及其在免疫疗法中的用途
CN112251405A (zh) * 2020-10-15 2021-01-22 大连天星生物技术有限责任公司 一种体外高效诱导扩增nk细胞的方法
CN112285083B (zh) * 2020-10-28 2022-01-07 上海睿钰生物科技有限公司 一种细胞杀伤效力的评价方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5415874A (en) * 1989-10-31 1995-05-16 The Board Of Trustees Of The Leland Stanford Junior University Natural killer cell lines and clones with antigen specificity
JP3381224B2 (ja) * 1996-04-17 2003-02-24 ベーリンガー マンハイム ゲゼルシャフト ミット ベシュレンクテル ハフツング リンパ球を生産し、そして増加させる方法
FR2775692B1 (fr) * 1998-03-03 2000-06-16 Roussy Inst Gustave Methodes d'activation de cellules tueuses naturelles (nk) et moyens de mise en oeuvre

Also Published As

Publication number Publication date
KR20030032905A (ko) 2003-04-26
JP2001149069A (ja) 2001-06-05
EP1233058A1 (de) 2002-08-21
CA2393322A1 (en) 2001-05-31
TWI224137B (en) 2004-11-21
CN1399675A (zh) 2003-02-26
HK1048498A1 (en) 2003-04-04
CN1237170C (zh) 2006-01-18
EP1233058B1 (de) 2006-12-20
ATE348876T1 (de) 2007-01-15
WO2001038494A1 (en) 2001-05-31
EP1233058A4 (de) 2003-01-15
JP3619853B2 (ja) 2005-02-16

Similar Documents

Publication Publication Date Title
DE60032508D1 (de) VERFAHREN ZUR VERMEHRUNG VON NATüRLICHEN KILLERZELLEN
ATE270323T1 (de) Zusammensetzungen und verfahren zur stimulierung der proliferation und der differenzierung von menschlichen fetalen und erwachsenen pankreatischen zellen ex vivo
WO2002072762A3 (en) Use of rna interference for the creation of lineage specific es and other undifferentiated cells and production of differentiated cells in vitro by co-culture
IL210618A0 (en) Population of multipotent adult stem cells expressing telomerase and being cd45- and glycophorin a-, methods for their preparation and uses
DE69836491D1 (de) Fibrinmikrokugeln und deren verwendungen
WO2001036589A3 (en) Human ex vivo immune system
WO2004055155A3 (en) Methods of preparing feeder cells-free, xeno-free human embryonic stem cells and stem cell cultures prepared using same
DE69030765D1 (de) Medien zur zellzucht und verfahren dazu
DE69329779D1 (de) Verfahren zur behandlung geschädigter und verminderter zellen
DK1085083T3 (da) Dyrkningsmedium for dyreceller og fremgangsmåde til proteinfremstilling under anvendelse af dette
WO2002010350A1 (en) Method of proliferating natural killer cells
ATE479743T1 (de) Verfahren zur herstellung von zellkulturen aus biologischen präparaten für chemotherapeutische und andere assays
ATE335808T1 (de) Herstellung von zellsuspensionen
DE60037007D1 (de) Angereicherte zentralnervensystem-zellpopulationen
EP1687413B8 (de) Verfahren zur differenzierung einer mesenchym-stammzelle zu einer nervenzelle sowie die nervenzelle enthaltende pharmazeutische zusammensetzung gegen eine neurodegenerative krankheit
DE69940753D1 (de) Verfahren zur Einführung von heterologischen Zellen in Fische
ATE314461T1 (de) Vermehrte und genetisch modifizierte populationen menschlicher hämatopoitischer stammzellen
ATE227996T1 (de) Zusammensetzung und verfahren zur regulierung von zellproliferation und zelltod
DE60039160D1 (de) Verwendung von erbb-rezeptorliganden zur behandlung von diabetes
TW200510011A (en) A method for regeneration of bone
FR2848565B1 (fr) Lignee de cellules dendritiques gen2.2
MXPA03009312A (es) Metodo para trasplante autologo.
GB2379446A (en) Cells,culture methods and their uses
ATE341630T1 (de) Verwendung von pankreatischer procarboxypeptidase b zur herstellung von insulin
ES2132027A1 (es) Desarrollo de una piel artificial mediante cultivo de queratinocitos sobre una base de fibrina y fibroblastos humanos y metodo de preparacion de esta piel para trasplante.

Legal Events

Date Code Title Description
8332 No legal effect for de